2024-10-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AXSM
Axsome Therapeutics, Inc.
|
Buy |
19.6% |
0% |
2024-10-18 |
The percentage of cash held in the portfolio is:
80.4%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-09-12 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
PODD |
Sell
All
|
11.4% |
Assets Rebalanced
None
2024-09-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PODD
Insulet Corporation
|
Buy |
20.69% |
3.96% |
2024-08-29 |
The percentage of cash held in the portfolio is:
79.31%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
APLS |
Sell
All
|
-5.21% |
Assets Rebalanced
None
2024-09-04 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
19.38% |
-2.65% |
2024-08-22 |
PODD
Insulet Corporation
|
Buy |
20.14% |
1.11% |
2024-08-29 |
The percentage of cash held in the portfolio is:
60.48%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
NEOG |
Sell
All
|
-6.34% |
Assets Rebalanced
None
2024-08-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
19.01% |
-4.2% |
2024-08-22 |
NEOG
Neogen Corporation
|
Buy |
19.42% |
-2.15% |
2024-08-28 |
PODD
Insulet Corporation
|
Buy |
19.86% |
0% |
2024-08-29 |
The percentage of cash held in the portfolio is:
41.71%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
19.5% |
-0.64% |
2024-08-22 |
NEOG
Neogen Corporation
|
Buy |
19.63% |
0% |
2024-08-28 |
The percentage of cash held in the portfolio is:
60.88%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
19.6% |
0% |
2024-08-22 |
The percentage of cash held in the portfolio is:
80.4%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-14 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
RMD |
Sell
All
|
5.88% |
Assets Rebalanced
None
2024-08-01 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RMD
ResMed Inc.
|
Buy |
19.66% |
2.5% |
2024-07-31 |
The percentage of cash held in the portfolio is:
80.34%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
RCM |
Sell
All
|
-1.15% |
Assets Rebalanced
None
2024-07-31 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
20.92% |
-1% |
2024-07-18 |
RMD
ResMed Inc.
|
Buy |
19.27% |
0% |
2024-07-31 |
The percentage of cash held in the portfolio is:
59.81%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
CLDX |
Sell
All
|
-12.36% |
Assets Rebalanced
None
2024-07-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
20.48% |
-0.19% |
2024-07-18 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
20.07% |
1.6% |
2024-07-26 |
The percentage of cash held in the portfolio is:
59.45%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ATRC |
Sell
All
|
-12.65% |
Assets Rebalanced
None
2024-07-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ATRC
AtriCure, Inc.
|
Buy |
18.95% |
-7% |
2024-07-17 |
RCM
R1 RCM Inc.
|
Buy |
20.2% |
-0.84% |
2024-07-18 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
19.62% |
0% |
2024-07-26 |
The percentage of cash held in the portfolio is:
41.24%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-25 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ATRC
AtriCure, Inc.
|
Buy |
19.18% |
-5.18% |
2024-07-17 |
RCM
R1 RCM Inc.
|
Buy |
20.41% |
0.92% |
2024-07-18 |
The percentage of cash held in the portfolio is:
60.41%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
SAGE |
Sell
All
|
-11.55% |
Assets Rebalanced
None
2024-07-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
SAGE
Sage Therapeutics, Inc.
|
Buy |
20.19% |
3.54% |
2024-07-12 |
ATRC
AtriCure, Inc.
|
Buy |
19.32% |
-0.91% |
2024-07-17 |
RCM
R1 RCM Inc.
|
Buy |
19.5% |
0% |
2024-07-18 |
The percentage of cash held in the portfolio is:
40.99%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-17 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
SAGE
Sage Therapeutics, Inc.
|
Buy |
20.17% |
3.62% |
2024-07-12 |
ATRC
AtriCure, Inc.
|
Buy |
19.46% |
0% |
2024-07-17 |
The percentage of cash held in the portfolio is:
60.37%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-12 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
SAGE
Sage Therapeutics, Inc.
|
Buy |
19.6% |
0% |
2024-07-12 |
The percentage of cash held in the portfolio is:
80.4%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-09 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ACAD |
Sell
All
|
2.77% |
Assets Rebalanced
None
2024-07-04 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
19.24% |
-1.83% |
2024-06-25 |
The percentage of cash held in the portfolio is:
80.76%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
STAA |
Sell
All
|
1.87% |
Assets Rebalanced
None
2024-06-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
19.32% |
-1.76% |
2024-06-25 |
STAA
STAAR Surgical Company
|
Buy |
19.67% |
0% |
2024-06-26 |
The percentage of cash held in the portfolio is:
61.01%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-06-25 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
19.6% |
0% |
2024-06-25 |
The percentage of cash held in the portfolio is:
80.4%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-05-30 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
BCRX |
Sell
All
|
-3.3% |
Assets Rebalanced
None
2024-05-24 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
BCRX
BioCryst Pharmaceuticals, Inc.
|
Buy |
19.92% |
-0.47% |
2024-05-16 |
The percentage of cash held in the portfolio is:
80.08%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
PODD |
Sell
All
|
-7.87% |
Assets Rebalanced
None
2024-05-20 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
BCRX
BioCryst Pharmaceuticals, Inc.
|
Buy |
19.45% |
-1.26% |
2024-05-16 |
PODD
Insulet Corporation
|
Buy |
19.89% |
1.02% |
2024-05-17 |
The percentage of cash held in the portfolio is:
60.67%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
OMCL |
Sell
All
|
1.03% |
Assets Rebalanced
None
2024-05-17 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OMCL
Omnicell, Inc.
|
Buy |
19.81% |
5.08% |
2024-05-06 |
BCRX
BioCryst Pharmaceuticals, Inc.
|
Buy |
19.81% |
1.73% |
2024-05-16 |
PODD
Insulet Corporation
|
Buy |
19.46% |
0% |
2024-05-17 |
The percentage of cash held in the portfolio is:
40.92%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-05-16 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OMCL
Omnicell, Inc.
|
Buy |
18.97% |
-0.86% |
2024-05-06 |
BCRX
BioCryst Pharmaceuticals, Inc.
|
Buy |
19.76% |
0% |
2024-05-16 |
The percentage of cash held in the portfolio is:
61.27%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-05-13 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OMCL
Omnicell, Inc.
|
Buy |
19.1% |
-0.03% |
2024-05-06 |
The percentage of cash held in the portfolio is:
80.9%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
PTCT |
Sell
All
|
12.88% |
Assets Rebalanced
None
2024-05-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
21.98% |
15.54% |
2024-04-29 |
OMCL
Omnicell, Inc.
|
Buy |
19.01% |
0% |
2024-05-06 |
The percentage of cash held in the portfolio is:
59.02%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-04-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
19.6% |
0% |
2024-04-29 |
The percentage of cash held in the portfolio is:
80.4%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-04-11 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
TNDM |
Sell
All
|
-2.07% |
Assets Rebalanced
None
2024-03-28 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
19.6% |
0% |
2024-03-28 |
The percentage of cash held in the portfolio is:
80.4%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-03-21 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
BAX |
Sell
All
|
-2.7% |
Assets Rebalanced
None
2024-03-19 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
BAX
Baxter International Inc.
|
Buy |
18.5% |
-3.37% |
2024-03-07 |
The percentage of cash held in the portfolio is:
81.5%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
RCM |
Sell
All
|
-7.19% |
Assets Rebalanced
None
2024-03-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
BAX
Baxter International Inc.
|
Buy |
18.44% |
-3.21% |
2024-03-07 |
RCM
R1 RCM Inc.
|
Buy |
18.14% |
-4.72% |
2024-03-08 |
The percentage of cash held in the portfolio is:
63.42%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
THC |
Sell
All
|
4.78% |
NTRA |
Sell
All
|
0.12% |
Assets Rebalanced
None
2024-03-12 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
THC
Tenet Healthcare Corporation
|
Buy |
20.87% |
2.95% |
2024-03-04 |
NTRA
Natera, Inc.
|
Buy |
20.24% |
-0.15% |
2024-03-04 |
BAX
Baxter International Inc.
|
Buy |
19.06% |
1.14% |
2024-03-07 |
RCM
R1 RCM Inc.
|
Buy |
18.64% |
-1.06% |
2024-03-08 |
The percentage of cash held in the portfolio is:
21.2%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
KRYS |
Sell
All
|
8.53% |
Assets Rebalanced
None
2024-03-08 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
KRYS
Krystal Biotech, Inc.
|
Buy |
18.91% |
7.95% |
2024-02-27 |
THC
Tenet Healthcare Corporation
|
Buy |
20.92% |
4.1% |
2024-03-04 |
NTRA
Natera, Inc.
|
Buy |
20.6% |
2.52% |
2024-03-04 |
BAX
Baxter International Inc.
|
Buy |
18.89% |
1.16% |
2024-03-07 |
RCM
R1 RCM Inc.
|
Buy |
18.67% |
0% |
2024-03-08 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-03-07 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
KRYS
Krystal Biotech, Inc.
|
Buy |
19.49% |
11.06% |
2024-02-27 |
THC
Tenet Healthcare Corporation
|
Buy |
20.78% |
3.23% |
2024-03-04 |
NTRA
Natera, Inc.
|
Buy |
20.31% |
0.91% |
2024-03-04 |
BAX
Baxter International Inc.
|
Buy |
18.71% |
0% |
2024-03-07 |
The percentage of cash held in the portfolio is:
20.71%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-03-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
KRYS
Krystal Biotech, Inc.
|
Buy |
19.36% |
8.82% |
2024-02-27 |
THC
Tenet Healthcare Corporation
|
Buy |
20.68% |
1.35% |
2024-03-04 |
NTRA
Natera, Inc.
|
Buy |
20% |
-2% |
2024-03-04 |
The percentage of cash held in the portfolio is:
39.96%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
BPMC |
Sell
All
|
-1.73% |
Assets Rebalanced
None
2024-03-04 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
BPMC
Blueprint Medicines Corporation
|
Buy |
18.45% |
4.24% |
2024-02-21 |
KRYS
Krystal Biotech, Inc.
|
Buy |
18.86% |
6.89% |
2024-02-27 |
THC
Tenet Healthcare Corporation
|
Buy |
20.23% |
0% |
2024-03-04 |
NTRA
Natera, Inc.
|
Buy |
20.23% |
0% |
2024-03-04 |
The percentage of cash held in the portfolio is:
22.23%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
RARE |
Sell
All
|
9.75% |
Assets Rebalanced
None
2024-03-01 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
19.07% |
5.72% |
2024-02-19 |
BPMC
Blueprint Medicines Corporation
|
Buy |
18.5% |
2.49% |
2024-02-21 |
KRYS
Krystal Biotech, Inc.
|
Buy |
18.28% |
1.57% |
2024-02-27 |
The percentage of cash held in the portfolio is:
44.15%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
RCM |
Sell
All
|
25.78% |
Assets Rebalanced
None
2024-02-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
22.84% |
28.83% |
2024-02-16 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
19.12% |
7.83% |
2024-02-19 |
BPMC
Blueprint Medicines Corporation
|
Buy |
18.56% |
4.6% |
2024-02-21 |
KRYS
Krystal Biotech, Inc.
|
Buy |
18.38% |
3.87% |
2024-02-27 |
The percentage of cash held in the portfolio is:
21.1%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
BRKR |
Sell
All
|
8.03% |
Assets Rebalanced
None
2024-02-27 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
BRKR
Bruker Corporation
|
Buy |
19.11% |
4.43% |
2024-02-15 |
RCM
R1 RCM Inc.
|
Buy |
22.76% |
24.35% |
2024-02-16 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
18.8% |
2.72% |
2024-02-19 |
BPMC
Blueprint Medicines Corporation
|
Buy |
19.08% |
4.16% |
2024-02-21 |
KRYS
Krystal Biotech, Inc.
|
Buy |
18.26% |
0% |
2024-02-27 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
IART |
Sell
All
|
0.5% |
Assets Rebalanced
None
2024-02-21 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IART
Integra LifeSciences Holdings Corporation
|
Buy |
20.23% |
2.89% |
2024-02-13 |
BRKR
Bruker Corporation
|
Buy |
19.92% |
1.31% |
2024-02-15 |
RCM
R1 RCM Inc.
|
Buy |
18.95% |
-3.58% |
2024-02-16 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
19.23% |
-2.15% |
2024-02-19 |
BPMC
Blueprint Medicines Corporation
|
Buy |
19.67% |
0% |
2024-02-21 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-02-19 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IART
Integra LifeSciences Holdings Corporation
|
Buy |
20.01% |
2.53% |
2024-02-13 |
BRKR
Bruker Corporation
|
Buy |
19.95% |
2.21% |
2024-02-15 |
RCM
R1 RCM Inc.
|
Buy |
18.99% |
-2.69% |
2024-02-16 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
19.52% |
0% |
2024-02-19 |
The percentage of cash held in the portfolio is:
21.52%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-02-16 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IART
Integra LifeSciences Holdings Corporation
|
Buy |
19.89% |
1.87% |
2024-02-13 |
BRKR
Bruker Corporation
|
Buy |
19.54% |
0.06% |
2024-02-15 |
RCM
R1 RCM Inc.
|
Buy |
19.52% |
0% |
2024-02-16 |
The percentage of cash held in the portfolio is:
41.05%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-02-15 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IART
Integra LifeSciences Holdings Corporation
|
Buy |
19.5% |
-0.64% |
2024-02-13 |
BRKR
Bruker Corporation
|
Buy |
19.63% |
0% |
2024-02-15 |
The percentage of cash held in the portfolio is:
60.88%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-02-13 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IART
Integra LifeSciences Holdings Corporation
|
Buy |
19.6% |
0% |
2024-02-13 |
The percentage of cash held in the portfolio is:
80.4%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2023-12-01 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
LNTH |
Sell
All
|
5.09% |
Assets Rebalanced
None
2023-11-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
LNTH
Lantheus Holdings, Inc.
|
Buy |
19.93% |
1.23% |
2023-11-17 |
The percentage of cash held in the portfolio is:
80.07%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
THC |
Sell
All
|
13.68% |
Assets Rebalanced
None
2023-11-22 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
THC
Tenet Healthcare Corporation
|
Buy |
20.61% |
13.21% |
2023-11-15 |
LNTH
Lantheus Holdings, Inc.
|
Buy |
19.74% |
-0.04% |
2023-11-17 |
The percentage of cash held in the portfolio is:
59.65%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
BMRN |
Sell
All
|
3.01% |
Assets Rebalanced
None
2023-11-20 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
BMRN
BioMarin Pharmaceutical Inc.
|
Buy |
17.54% |
2.37% |
2023-11-08 |
THC
Tenet Healthcare Corporation
|
Buy |
20.02% |
9.03% |
2023-11-15 |
LNTH
Lantheus Holdings, Inc.
|
Buy |
19.93% |
0.07% |
2023-11-17 |
The percentage of cash held in the portfolio is:
42.51%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ALNY |
Sell
All
|
-2.16% |
IQV |
Sell
All
|
3.85% |
Assets Rebalanced
None
2023-11-17 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ALNY
Alnylam Pharmaceuticals, Inc.
|
Buy |
20.54% |
0.97% |
2023-11-06 |
IQV
IQVIA Holdings Inc.
|
Buy |
21.12% |
3.85% |
2023-11-06 |
BMRN
BioMarin Pharmaceutical Inc.
|
Buy |
17.69% |
2.01% |
2023-11-08 |
THC
Tenet Healthcare Corporation
|
Buy |
18.48% |
-0.55% |
2023-11-15 |
LNTH
Lantheus Holdings, Inc.
|
Buy |
20.16% |
0% |
2023-11-17 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
RMD |
Sell
All
|
-0.8% |
Assets Rebalanced
None
2023-11-15 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RMD
ResMed Inc.
|
Buy |
20.15% |
-1.86% |
2023-11-03 |
ALNY
Alnylam Pharmaceuticals, Inc.
|
Buy |
20.85% |
1.58% |
2023-11-06 |
IQV
IQVIA Holdings Inc.
|
Buy |
20.87% |
1.66% |
2023-11-06 |
BMRN
BioMarin Pharmaceutical Inc.
|
Buy |
17.37% |
-0.74% |
2023-11-08 |
THC
Tenet Healthcare Corporation
|
Buy |
18.76% |
0% |
2023-11-15 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2023-11-10 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RMD
ResMed Inc.
|
Buy |
20.08% |
-4.45% |
2023-11-03 |
ALNY
Alnylam Pharmaceuticals, Inc.
|
Buy |
20.66% |
-1.69% |
2023-11-06 |
IQV
IQVIA Holdings Inc.
|
Buy |
20.45% |
-2.68% |
2023-11-06 |
BMRN
BioMarin Pharmaceutical Inc.
|
Buy |
17.55% |
-2.07% |
2023-11-08 |
The percentage of cash held in the portfolio is:
21.25%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CYTK |
Sell
All
|
-8.84% |
Assets Rebalanced
None
2023-11-08 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RMD
ResMed Inc.
|
Buy |
20.14% |
0.11% |
2023-11-03 |
CYTK
Cytokinetics, Incorporated
|
Buy |
19.85% |
-1.29% |
2023-11-06 |
ALNY
Alnylam Pharmaceuticals, Inc.
|
Buy |
20.46% |
1.7% |
2023-11-06 |
IQV
IQVIA Holdings Inc.
|
Buy |
20.41% |
1.46% |
2023-11-06 |
BMRN
BioMarin Pharmaceutical Inc.
|
Buy |
17.15% |
0% |
2023-11-08 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2023-11-07 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RMD
ResMed Inc.
|
Buy |
20.8% |
2.52% |
2023-11-03 |
CYTK
Cytokinetics, Incorporated
|
Buy |
19.23% |
-5.2% |
2023-11-06 |
ALNY
Alnylam Pharmaceuticals, Inc.
|
Buy |
20.26% |
-0.12% |
2023-11-06 |
IQV
IQVIA Holdings Inc.
|
Buy |
20.41% |
0.61% |
2023-11-06 |
The percentage of cash held in the portfolio is:
19.31%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
KRYS |
Sell
All
|
-15.05% |
Assets Rebalanced
None
2023-11-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RMD
ResMed Inc.
|
Buy |
19.88% |
1.81% |
2023-11-03 |
CYTK
Cytokinetics, Incorporated
|
Buy |
19.53% |
0% |
2023-11-06 |
KRYS
Krystal Biotech, Inc.
|
Buy |
19.53% |
0% |
2023-11-06 |
ALNY
Alnylam Pharmaceuticals, Inc.
|
Buy |
19.53% |
0% |
2023-11-06 |
IQV
IQVIA Holdings Inc.
|
Buy |
19.53% |
0% |
2023-11-06 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2023-11-03 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RMD
ResMed Inc.
|
Buy |
19.6% |
0% |
2023-11-03 |
The percentage of cash held in the portfolio is:
80.4%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2023-10-26 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
STAA |
Sell
All
|
-11.44% |
Assets Rebalanced
None
2023-10-23 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
STAA
STAAR Surgical Company
|
Buy |
18.84% |
-4.71% |
2023-10-18 |
The percentage of cash held in the portfolio is:
81.16%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
VRTX |
Sell
All
|
0.34% |
Assets Rebalanced
None
2023-10-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
VRTX
Vertex Pharmaceuticals Incorporated
|
Buy |
20.16% |
3.57% |
2023-10-09 |
STAA
STAAR Surgical Company
|
Buy |
19.46% |
0% |
2023-10-18 |
The percentage of cash held in the portfolio is:
60.38%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2023-10-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
VRTX
Vertex Pharmaceuticals Incorporated
|
Buy |
19.6% |
0% |
2023-10-09 |
The percentage of cash held in the portfolio is:
80.4%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2023-09-22 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CNC |
Sell
All
|
4.67% |
Assets Rebalanced
None
2023-09-21 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CNC
Centene Corporation
|
Buy |
20.18% |
2.47% |
2023-09-08 |
The percentage of cash held in the portfolio is:
79.82%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
HQY |
Sell
All
|
2.34% |
Assets Rebalanced
None
2023-09-20 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
HQY
HealthEquity, Inc.
|
Buy |
20.17% |
2.31% |
2023-09-07 |
CNC
Centene Corporation
|
Buy |
20.13% |
2.12% |
2023-09-08 |
The percentage of cash held in the portfolio is:
59.71%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
STAA |
Sell
All
|
-7.33% |
Assets Rebalanced
None
2023-09-12 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
HQY
HealthEquity, Inc.
|
Buy |
19.76% |
0.99% |
2023-09-07 |
CNC
Centene Corporation
|
Buy |
19.55% |
-0.03% |
2023-09-08 |
STAA
STAAR Surgical Company
|
Buy |
19.56% |
0% |
2023-09-12 |
The percentage of cash held in the portfolio is:
41.13%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2023-09-08 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
HQY
HealthEquity, Inc.
|
Buy |
20.06% |
2.93% |
2023-09-07 |
CNC
Centene Corporation
|
Buy |
19.49% |
0% |
2023-09-08 |
The percentage of cash held in the portfolio is:
60.46%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2023-09-07 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
HQY
HealthEquity, Inc.
|
Buy |
19.6% |
0% |
2023-09-07 |
The percentage of cash held in the portfolio is:
80.4%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2023-09-06 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
IONS |
Sell
All
|
-3.72% |
Assets Rebalanced
None
2023-08-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IONS
Ionis Pharmaceuticals, Inc.
|
Buy |
19.6% |
0% |
2023-08-29 |
The percentage of cash held in the portfolio is:
80.4%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2023-08-16 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
INSM |
Sell
All
|
1.72% |
Assets Rebalanced
None
2023-08-15 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
INSM
Insmed Incorporated
|
Buy |
20.56% |
0.77% |
2023-08-02 |
The percentage of cash held in the portfolio is:
79.44%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
HQY |
Sell
All
|
3.18% |
Assets Rebalanced
None
2023-08-07 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
HQY
HealthEquity, Inc.
|
Buy |
20.32% |
-1.43% |
2023-08-01 |
INSM
Insmed Incorporated
|
Buy |
20.53% |
-0.63% |
2023-08-02 |
The percentage of cash held in the portfolio is:
59.15%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ALGN |
Sell
All
|
-6.2% |
Assets Rebalanced
None
2023-08-04 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ALGN
Align Technology, Inc.
|
Buy |
19.36% |
-4.95% |
2023-07-28 |
HQY
HealthEquity, Inc.
|
Buy |
20.87% |
2.46% |
2023-08-01 |
INSM
Insmed Incorporated
|
Buy |
20.43% |
0.09% |
2023-08-02 |
The percentage of cash held in the portfolio is:
39.33%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ICUI |
Sell
All
|
-5.15% |
Assets Rebalanced
None
2023-08-03 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ALGN
Align Technology, Inc.
|
Buy |
19.54% |
-4.65% |
2023-07-28 |
ICUI
ICU Medical, Inc.
|
Buy |
19.73% |
-3.75% |
2023-08-01 |
HQY
HealthEquity, Inc.
|
Buy |
20.4% |
-0.44% |
2023-08-01 |
INSM
Insmed Incorporated
|
Buy |
20.2% |
-1.63% |
2023-08-02 |
The percentage of cash held in the portfolio is:
20.13%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
TDOC |
Sell
All
|
-11.76% |
Assets Rebalanced
None
2023-08-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ALGN
Align Technology, Inc.
|
Buy |
19.6% |
-2.26% |
2023-07-28 |
ICUI
ICU Medical, Inc.
|
Buy |
19.66% |
-1.95% |
2023-08-01 |
TDOC
Teladoc Health, Inc.
|
Buy |
18.69% |
-6.79% |
2023-08-01 |
HQY
HealthEquity, Inc.
|
Buy |
19.95% |
-0.53% |
2023-08-01 |
INSM
Insmed Incorporated
|
Buy |
20.09% |
0% |
2023-08-02 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2023-08-01 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ALGN
Align Technology, Inc.
|
Buy |
19.3% |
-1.93% |
2023-07-28 |
ICUI
ICU Medical, Inc.
|
Buy |
19.68% |
0% |
2023-08-01 |
TDOC
Teladoc Health, Inc.
|
Buy |
19.68% |
0% |
2023-08-01 |
HQY
HealthEquity, Inc.
|
Buy |
19.68% |
0% |
2023-08-01 |
The percentage of cash held in the portfolio is:
21.68%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2023-07-28 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ALGN
Align Technology, Inc.
|
Buy |
19.6% |
0% |
2023-07-28 |
The percentage of cash held in the portfolio is:
80.4%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2023-06-21 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
HQY |
Sell
All
|
-4.13% |
Assets Rebalanced
None
2023-06-07 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
HQY
HealthEquity, Inc.
|
Buy |
19.6% |
0% |
2023-06-07 |
The percentage of cash held in the portfolio is:
80.4%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2023-05-16 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
BMRN |
Sell
All
|
-1.86% |
Assets Rebalanced
None
2023-05-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
BMRN
BioMarin Pharmaceutical Inc.
|
Buy |
19.6% |
0% |
2023-05-02 |
The percentage of cash held in the portfolio is:
80.4%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2023-04-27 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
MASI |
Sell
All
|
-4.78% |
Assets Rebalanced
None
2023-04-17 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
MASI
Masimo Corporation
|
Buy |
18.86% |
-2.36% |
2023-04-14 |
The percentage of cash held in the portfolio is:
81.14%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
SGRY |
Sell
All
|
7.08% |
ALGN |
Sell
All
|
2.43% |
Assets Rebalanced
None
2023-04-14 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
SGRY
Surgery Partners, Inc.
|
Buy |
20.64% |
7.25% |
2023-04-03 |
ALGN
Align Technology, Inc.
|
Buy |
19.66% |
2.16% |
2023-04-03 |
MASI
Masimo Corporation
|
Buy |
19.23% |
0% |
2023-04-14 |
The percentage of cash held in the portfolio is:
40.47%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2023-04-03 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
SGRY
Surgery Partners, Inc.
|
Buy |
19.6% |
0% |
2023-04-03 |
ALGN
Align Technology, Inc.
|
Buy |
19.6% |
0% |
2023-04-03 |
The percentage of cash held in the portfolio is:
60.8%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2023-02-22 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
HQY |
Sell
All
|
5.17% |
Assets Rebalanced
None
2023-02-10 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
HQY
HealthEquity, Inc.
|
Buy |
19.67% |
-3.35% |
2023-02-08 |
The percentage of cash held in the portfolio is:
80.33%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
TNDM |
Sell
All
|
-8.36% |
PKI |
Sell
All
|
-5.28% |
Assets Rebalanced
None
2023-02-08 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
19.3% |
-2.05% |
2023-02-03 |
PKI
PerkinElmer, Inc.
|
Buy |
19.04% |
-3.38% |
2023-02-03 |
HQY
HealthEquity, Inc.
|
Buy |
19.89% |
0% |
2023-02-08 |
The percentage of cash held in the portfolio is:
41.77%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2023-02-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
19.59% |
0.13% |
2023-02-03 |
PKI
PerkinElmer, Inc.
|
Buy |
19.2% |
-1.82% |
2023-02-03 |
The percentage of cash held in the portfolio is:
61.21%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
EXEL |
Sell
All
|
4.9% |
Assets Rebalanced
None
2023-02-03 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
EXEL
Exelixis, Inc.
|
Buy |
20.07% |
5.26% |
2023-01-23 |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
19.48% |
0% |
2023-02-03 |
PKI
PerkinElmer, Inc.
|
Buy |
19.48% |
0% |
2023-02-03 |
The percentage of cash held in the portfolio is:
40.97%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2023-01-27 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
EXEL
Exelixis, Inc.
|
Buy |
20.16% |
5.86% |
2023-01-23 |
The percentage of cash held in the portfolio is:
79.84%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
HUM |
Sell
All
|
1.03% |
ISEE |
Sell
All
|
7.69% |
Assets Rebalanced
None